title: Sitagliptin and Cardiovascular Outcomes in Type 2 Diabetes.
authors.forename: Martin K
authors.initials: MK
authors.lastname: Rutter
authors.forename: Alison K
authors.initials: AK
authors.lastname: Wright
authors.forename: Darren M
authors.initials: DM
authors.lastname: Ashcroft
mesh_terms: D002318:Cardiovascular Diseases / Q000150:complications*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D011719:Pyrazines / Q000009:adverse effects*; D014230:Triazoles / Q000009:adverse effects*
chemical_list: D007004:Hypoglycemic Agents; D011719:Pyrazines; D014230:Triazoles